PDCD1 and neoplasm: Although anti–programmed cell death 1 (anti–PD-1) treatment efficiently inhibited tumor progression in tumor-bearing WT mice, this efficiency was largely suppressed in tumor-bearing KO mice (Figure 3D), indicating that SENP7-dependent CD8+ T cell proliferation contributed to the antitumor immune response to checkpoint blockade.